OKLAHOMA CITY, Aug. 10, 2026 /PRNewswire/ — Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the way for commercial availability of the technology across the United Arab Emirates.
A tumor is more than its cancer cells. Immune cells, blood vessels and other surrounding tissue influence how a cancer grows and responds to treatment. Two tumors containing the same cell types can respond very differently to the same therapy depending on how those cells are arranged. Spatial proteomics captures this organization in molecular detail, but the resulting data, which contain many different variables, are difficult to interpret and compare across studies.
Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing.
Labcorp’s CDx is designed to detect BRAF V600E and V600K melanoma mutations to determine which patients are eligible for BRAF inhibitor regimens.
Peer-reviewed data from nearly 30,000 real-world treatments reinforce the role of NerivioÒ, a drug-free REN wearable, as an alternative for veterans managing this complex, often service-related condition